Author: Dr. David Lowemann

FDA Approves New Drug to Treat Rosacea

Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term skin condition called rosacea. Rosacea is a skin condition causing chronic inflammation of the facial skin and is often classified into four types.The… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]

Published on November 4, 2024

Too Many Meds Can Harm Alzheimer’s Patients

Alzheimer’s disease patients prescribed fistfuls of daily drugs are at greater risk of harm, a new study warns. Patients with Alzheimer’s prescribed five or more daily medications suffer from more symptoms, falls and hospitalizations, and they are at greater risk of death,… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on November 4, 2024

Loneliness Significantly Increases Dementia Risk

A new study finds that lonely people are more than 30% more likely to develop dementia than those who don’t experience loneliness. Florida State University College of Medicine researchers analyzed data from more than 600,000 men and women worldwide, combining results from… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on November 4, 2024